Artículo original
Experiencia del uso de la toxina botulínica tipo A para el tratamiento sintomático del epiblefaron en pacientes menores de 2 años
Treatment of symptomatic epiblepharon with Botulinum toxin type A in patients under 2years of age
Y. de la Fuente Díez
, O. Olvera Morales, C.Y. Chen López, J.L. Tovilla Canales, A. Nava Castañeda
Autor para correspondencia
Departamento de Órbita y Oculoplástica, Instituto Oftalmológico Conde de Valenciana (I.A.P.), Ciudad de México, CDMX, México
Leído
2458
Vecesse ha leído el artículo
73
Total PDF
2385
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 32 | 4 | 36 |
| 2025 9 | 60 | 4 | 64 |
| 2025 8 | 48 | 0 | 48 |
| 2025 7 | 34 | 2 | 36 |
| 2025 6 | 38 | 1 | 39 |
| 2025 5 | 51 | 0 | 51 |
| 2025 4 | 41 | 1 | 42 |
| 2025 3 | 64 | 6 | 70 |
| 2025 2 | 67 | 0 | 67 |
| 2025 1 | 99 | 4 | 103 |
| 2024 12 | 96 | 1 | 97 |
| 2024 11 | 58 | 1 | 59 |
| 2024 10 | 62 | 0 | 62 |
| 2024 9 | 128 | 2 | 130 |
| 2024 8 | 120 | 0 | 120 |
| 2024 7 | 114 | 1 | 115 |
| 2024 6 | 62 | 3 | 65 |
| 2024 5 | 47 | 1 | 48 |
| 2024 4 | 74 | 0 | 74 |
| 2024 3 | 82 | 1 | 83 |
| 2024 2 | 81 | 2 | 83 |
| 2024 1 | 73 | 2 | 75 |
| 2023 12 | 44 | 0 | 44 |
| 2023 11 | 67 | 11 | 78 |
| 2023 10 | 83 | 2 | 85 |
| 2023 9 | 78 | 4 | 82 |
| 2023 8 | 97 | 1 | 98 |
| 2023 7 | 53 | 0 | 53 |
| 2023 6 | 69 | 0 | 69 |
| 2023 5 | 87 | 1 | 88 |
| 2023 4 | 59 | 0 | 59 |
| 2023 3 | 70 | 2 | 72 |
| 2023 2 | 20 | 0 | 20 |
| 2022 1 | 15 | 0 | 15 |
| 2022 12 | 4 | 2 | 6 |
| 2022 11 | 6 | 0 | 6 |
| 2022 10 | 5 | 0 | 5 |
| 2022 9 | 3 | 0 | 3 |
| 2022 8 | 3 | 0 | 3 |
| 2022 7 | 2 | 0 | 2 |
| 2022 6 | 3 | 0 | 3 |
| 2022 5 | 2 | 0 | 2 |
| 2022 4 | 13 | 2 | 15 |
| 2022 3 | 13 | 0 | 13 |
| 2022 2 | 5 | 0 | 5 |
| 2021 1 | 5 | 2 | 7 |
| 2020 1 | 8 | 2 | 10 |
| 2020 12 | 2 | 0 | 2 |
| 2020 11 | 1 | 0 | 1 |
| 2020 10 | 15 | 2 | 17 |
| 2020 8 | 1 | 0 | 1 |
| 2020 5 | 0 | 2 | 2 |
| 2020 4 | 3 | 2 | 5 |
| 2020 3 | 6 | 2 | 8 |
| 2020 2 | 12 | 0 | 12 |
Mostrar todo
